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Background: The tumor suppressor protein p16INK4a has been extensively studied in many tumors with very
different results, ranging from its loss to its clear overexpression, which may be associated with degree of tumor
differentiation and prognosis. However, its expression remains unclear in human retinoblastoma (RB), a common
malignant tumor of retina in childhood. The aim of this study was to explore the expression pattern of p16INK4a in
RB, and the correlation between p16INK4a expression and histopathological features of RB.
Methods: Sixty-five cases of RB were retrospectively analyzed. Paraffin-embedded blocks were retrieved from the
archives of ocular pathology department at Zhongshan Ophthalmic Center of Sun Yat-sen University, China. Serial
sections were cut and subjected to hematoxylin and eosin staining. Immunohistochemical staining was further
done with antibodies p16INK4a, CRX and Ki67. The correlation of p16 INK4a expression with CRX and Ki67 and
clinicopathological features of RB were analyzed.
Results: RB tumor histologically consists of various differentiation components including undifferentiated (UD) cells,
Homer-Wright rosettes (HWR) or Flexner-Winterstein rosettes (FWR) and fleurettes characteristic of photoreceptor
differentiation or Retinocytoma (RC). p16INK4a expression was negative in both fleurette region and the residual
retinal tissue adjacent to the tumor, weakly to moderately positive in FWR, strongly positive in both HWR and UD
region. However, CRX had the reverse expression patterns in comparison with p16INK4a. It was strongly positive in
photoreceptor cells within the residual retina and fleurettes, but weakly to moderately positive in UD area. Together
with Ki67 staining, high p16INK4a expression was associated with poor histological differentiation of RB tumors,
which had higher risk features with the optic nerve invasion and uveal invasion.
Conclusions: p16INK4a expression increased with the decreasing level of cell differentiation of RBs. RB tumors
extensively expressing p16INK4a tended to have higher risk features with poor prognosis. This study suggested that
p16INK4a would be a valuable molecular marker of RB to distinguish its histological phenotypes and to serve as a
predictor of its prognosis.
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Traditionally, level of neoplastic differentiation is a cru-
cial index of adjuvant chemotherapy and prognosis. Ret-
inoblastoma (RB), the most common primary malignant
intraocular tumor in childhood, has different patho-
logical phenotypes from undifferentiated tumor cells,
Homer-Wright rosettes (HWR) or Flexner-Winterstein
rosettes(FWR) to fleurettes. These phenotypes reflect to
some extent the level of tumor differentiation which is a
key factor in grade of retinoblastoma and prediction of
its prognosis [1,2]. For example, retinocytoma (RC), also
called retinoma, has been proposed to be the benign
variant of RB since it is largely composed of benign-
appearing cells with elongated eosinophilic fleurettes
similar to the inner segment of photoreceptor cells and
because it has better prognosis than RB in general [3-5].
However, these components with various degree of dif-
ferentiation have been a challenge to be morphologically
identified by researchers, sometimes even by experi-
enced pathologists. It would therefore be very useful to
find out a panel of molecular markers to distinguish
them and to predict progression of RB.
p16INK4a, a tumor suppressor protein, has played an im-
portant role in cell cycle control, cell senescence and tumor
development. It has been extensively studied in both benign
and malignant lesions with very different results, ranging
from its loss to its clear overexpression [6]. For instance, in
benign lesions such as nevi and neurofibroma, p16INK4a
overexpression was associated with senescence [7,8];
whereas in malignancy such as HPV-positive cervical cancer,
breast cancer and colorectal adenocarcinoma, it appeared to
be associated with high-grade tumors along with RB gene al-
terations [9-11]. In recent years, p16INK4a has been used as a
diagnostic marker to distinguish between benign and malig-
nant lesions, and some evidence suggests that it also plays a
prognostic role in tumors that overexpress p16INK4a [12].
p16INK4a expression in RB remains controversial, espe-
cially in regarding of its expression patterns in histological
phenotypes of RB [4,13,14]. Dimaras and colleagues re-
ported that p16INK4awas expressed in fleurette regions but
negative in undifferentiated regions [4]. Conversely, SE
Coupland et al. described a reverse expression pattern of
p16INK4a that was positive in undifferentiated areas of 23
RB tumors [14]. To better understand p16INK4aexpression
and its potential role in RB, we evaluated the expression
patterns of p16INK4a, Ki67 and CRX through a large co-
hort of 65 RB tumors. CRX is required for the terminal
differentiation and maintenance of photoreceptors [15]
and has been shown to be a differentiation marker of RB
[16,17]. Our results demonstrated that p16INK4a expres-
sion increased with the dedifferentiation of RB, showing
strongly positive in undifferentiated cells and HWR,
weakly to moderately positive in FWR, but negative in
well-differentiated cells with fleurettes. This expressiontrend of p16INK4a was consistent with that of Ki67, but re-
verse to that of CRX in RB tumors. The results indicated
that p16INK4a would be a valuable molecular marker of RB
in distinguishing histological phenotypes and in serving as
a predictor of its prognosis.
Methods
Tumor samples
Formalin-fixed, paraffin-embedded retinoblastoma blocks
were retrieved from the archives of ocular pathology de-
partment at Zhongshan Ophthalmic Center of Sun Yat-sen
University, China during a 3-year period (2008 to 2010).
The cases with chemotherapy or radiotherapy prior to enu-
cleation were excluded. Serial sections of 4 μm thick were
cut, and subjected to hematoxylin and eosin (HE) staining.
The tumor samples were divided into four groups accord-
ing to the level of cell differentiation: undifferentiated (UD)
group predominantly consisting of undifferentiated tumor
cells and pseudorosettes; HWR or FWR group in which ro-
settes accounted for over 70% of the lesion according to the
predominant rosette phenotype; and RC group in which
fleurettes characteristic of photoreceptor differentiation
accounted for over 60% of the lesion [1,2]. The study was
approved by Medical Ethical Committee of Zhongshan
Ophthalmic Center, Sun Yat-Sen University.
Slide preparation and immunohistochemistry
Sections were deparaffinized in xylene, re-hydrated and in-
cubated in 0.3% hydrogen peroxide (H2O2, Sigma, St. Louis,
USA) for 30 min to block endogenous peroxidase activity.
Antigen retrieval was achieved using 0.01 M citrate buffer,
pH 6, in a pressure cooker for 45 s. For immunohistochem-
istry, the sections were stained with rabbit anti-CRX (1:200)
(C7498, Sigma, St. Louis, USA), mouse anti-human p16INK4a
(ZJ11, Maixin-bio, China) and rabbit anti-Ki67 (1:200) (sc-
15402, Santa Cruz, California, USA) respectively. Signals
were detected using the Dako-Cytomation EnVision+ anti-
rabbit or anti-mouse secondary system. The slides were then
incubated in DAB solution (Vector Laboratories DAB sub-
strate kit for peroxidase) for approximately 1 min, then
washed in PBS and counterstained briefly in Harris
hematoxylin. Images were taken using a BX51 microscope
(Olympus, Japan). The primary antibody was replaced by di-
lution buffer as a negative control. The residual retinal tissue
adjacent to tumor was considered as an internal control.
The sections were semi-quantitatively evaluated for the
expression level of proteins according to reference with
modifications [18]. Briefly, the intensity of CRX and
p16INK4a expression was scored on a scale of 0–2: 0, nega-
tive, 1, weak, and 2, strong; whereas the extent of both
p16INK4a and Ki67 expressions was scored as followings:
grade 0, no staining; grade 1, < 40%; grade 2, 40-80%; and
grade 3, 80–100% of tumor cells in the respective lesion. To
analyze the association of p16INK4a with clinicopathological
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sion, both grade 2 and 3 as high expression. The high-risk
feature evaluation included the presence and extent of optic
nerve invasion and the massive choroidal invasion [19]. All
specimens were screened and evaluated by two experienced
pathologists blinded to the clinical information.
Statistical methods
Spearman’s rank test and the Kruskal-Wallis test were
used to analyze the progressive increase of p16INK4a
expression in various pathological types of RB. The asso-
ciation between the expression measured via immuno-
histochemistry and high-risk features was analyzed using
chi-squared tests and Kruskal-Wallis tests. In all ana-
lyses, p < 0.05 was accepted as statistically significant.
These analyses were performed using the SPSS 16.0 soft-
ware package (SPSS Inc., Chicago, Illinois, USA).
Results
Clinicopathological features
Clinicopathological features were summarized in Table 1.
Sixty-five enucleated eyeballs with RB were enrolled in
this study. In our population, males (63.1%, 41/65) out-
numbered females (36.9%, 24/65), with ages ranging
from 1.73 months to 9 years and a mean value of 21.7 ±
20.0 months. The UD group accounted for 58.5% (38/
65) of all tumors, and HWR 26.2% (17/65), FWR 10.8%
(7/65) and RC 4.6% (3/65). Patients in the UD and RC
groups were older than patients in the HWR and FWR
groups, on average.
Expression patterns of p16INK4a in retinoblastoma
Histologically, retinoblastoma consists of undifferentiated
small round cells with scant cytoplasm and large nucleus.
This tumor often contains certain amount of differentiated
cells with more cytoplasm depending on the level of differ-
entiation. The undifferentiated tumor cells usually scatter or
form pseudorosettes around the blood vessel. In contrast,
the differentiated cells can form specific structures from
HWR or FWR to fleurettes with the increasing level of cell
differentiation. In 65 cases, there were 3 tumors in RC that
predominantly comprised of fleurette surrounded by some







UD 29.9 ± 21.8 22 16 35
HWR 9.4 ± 6.3 13 4 14
FWR 7.5 ± 6.9 5 2 4
RC 20 ± 13.9 1 2 2
Total 21.7 ± 20.0 41 24 55
aGrouping was according to international intraocular retinoblastoma classification (Istructures was totally negative, which was similar to that in
the residual adjacent retinal tissue, but positive in the sur-
rounded tumor cells (Figure 1a, b). In FWR group, 4 out of
7 FWR weakly expressed p16INK4a, except for 3 cases (3/7)
with moderate to strong immunoreactivities primarily lo-
cated in the cytoplasm (Figure 2a,b). However, p16INK4a ex-
pression in HWR area was similar to that observed in
undifferentiated cells, most of which were strongly positive
but primarily located in the cytoplasm (Figure 3a, b). Com-
pared with the above groups, most of tumors (31/38) in the
UD group were strongly positive for p16INK4a, which was lo-
cated in both the cytoplasm and nucleus (Figure 4a, b), ex-
cept for 5 cases (5/38) that were primarily cytoplasmic
positive and 2 cases (2/38) that were weakly positive. As the
degree of differentiation increased from the UD group to
RC group, the expression level of p16INK4a decreased
(ρ=−0.770; p = 0.000; Spearman’s rank test).Correlation of p16INK4a expression with the level of cell
differentiation
To further determine the correlation of p16INK4a expression
with the level of cell differentiation, we detected the expres-
sion of both the photoreceptor differentiation marker CRX
and the cell proliferation marker Ki67 in consecutive sec-
tions of retinoblastoma samples. In RC group, the fleurette
strongly expressed CRX, but negatively Ki67 (Figure 1c, d),
with the similar patterns to photoreceptor cells in the re-
sidual adjacent retina. In FWR region, cells were moder-
ately to strongly positive for CRX with a few of Ki67
positive cells scattered (Figure 2c, d). In HWR region, cells
were moderately positive for CRX with more Ki67 positive
cells scattered (Figure 3c, d). Nevertheless, cells in UD re-
gion weakly to moderately expressed CRX with many Ki67
positive cells (Figure 4c, d). Therefore, considering together
with the expression of p16INK4a described above, our results
demonstrated that p16INK4a and Ki67 expression decreased,
but CRX increased with the increasing level of cell differen-
tiation. Using Spearman’s rank test, we found not only a
positive correlation between p16INK4a and Ki67 but also an
inverse correlation between p16INK4a and CRX, suggesting
a possible relationship between p16INK4a expression and the
degree of RB differentiation.Groupsa High risk feature
l Bilateral C D E Number (%)
3 8 16 14 14 (37)
3 2 11 4 6 (35)
3 2 3 2 1 (14)
1 2 1 0 0 (0)
10 14 31 20 21 (32)
IRC) [20].
Figure 1 Expressions of p16INK4a, CRX and Ki67 in a representative RB case from RC group (100x). a. HE staining showed well-differentiated RC
cells with typical fleurettes surrounded by moderately differentiated tumor cells; b. p16INK4a was negative in the RC region, but positive in the
surrounding tumor cells. A magnified image (insert) shows the transition zone between the RC and the tumor cells; c. CRX expression displayed the
opposite pattern to that of p16INK4a, being strongly positive in RC region but negative in the surrounding area; d. Ki67 expression was similar to that of
p16INK4a, with barely positive cells in RC region. All inserts, 200x.
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clinicopathological parameters
The correlation was summarized in Table 2. Of 65 RB
cases, 55 tumors (85%) had high expression of p16INK4a,
and 10 tumors (15%) low expression. Most of tumors withFigure 2 Expressions of p16INK4a, CRX and Ki67 in a representative RB
p16INK4a was moderately positive in FWR, but negative in the residual retin
FWR, similar to the photoreceptors in the residual retina. d. Ki67 expression
When comparing b and c, a complementary expression pattern between phigh level of p16INK4a expression originated from UD
(36/55) and HWR (16/55) groups, whereas most tumors
with low level of p16INK4a from RC (3/10) and FWR
(4/10). Statistic analysis showed the extent of p16INK4a ex-
pression among these four groups existed significantcase from FWR group (100×). a. HE staining showed FWR. b.
a adjacent to the tumor. c. CRX expression was strongly positive in
was similar to p16INK4a, with a few of positive cells scattered in FWR.
16INK4a and CRX is seen (black arrow). All inserts, 200x.
Figure 3 Expressions of p16INK4a, CRX and Ki67 in different histological phenotypes of one RB case from HWR group (100×). a. HE staining
showed 3 histological phenotypes of RB, including RC (in black frame), HWR (in red frame) and UD (in green frame). The yellow frame highlighted fleurette
structures in RC region with higher magnification (200x). b. The level of p16INK4a progressively increased from the region RC to HWR, then to UD. c. CRX
was strongly positive in both RC and HWR region, but weakly to moderately positive in UD. d. The number of Ki67 positive cells scattered was increased
from region RC, HWR to UD.
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mors with high expression of p16INK4a tended to have
higher risk features with either optic nerve invasion (22%)
or massive choroidal invasion (23%) even though statisti-
cally significant correlation was not found between theFigure 4 Expressions of p16INK4a, CRX and Ki67 in a representative R
predominantly consisted of UD cells with scanty cytoplasm and large nucle
cytoplasm and nucleus of most of tumor cells. c. CRX expression was weak
positive for Ki67, similar to p16INK4a. All inserts, 200x.extent of p16INK4a positivity and the presence of high-risk
features. One of the two weakly positive p16INK4a cases in
the UD group had high-risk features that tumor cells were
found in the line of surgical transaction. But no case with
massive choroidal invasion had HWR, FWR or RC groups.B case from UD group (40×). a. HE staining showed the tumor
us forming pseudorosettes. b. p16INK4a was strongly positive in both
ly to moderately positive in these tumor cells. d. Most of UD cells were
Table 2 The relationship between the extent of
p16INK4aexpression and clinicopathological parameters
P16INK4A P-value
Low (0–1)f High (2–3)










UD 2 (5%) 36 (95%)
P = 0.000c
HWR 1 (6%) 16 (94%)
FWR 4 (57%) 3 (43%)
RC 3 (100%) 0 (0%)
High risk feature
Optic nerve invasion 1 (10%) 14 (22%) P = 0.676b
Massive choroidal invasiond 0 (0%) 15 (23%) P = 0.100b
aMann–Whitney rank sum test; bFisher’s exact test.cKruskal-Wallis test. dThe
criterion of massive choroidal invasion was the maximum diameter (thickness
or width) equal to 3 mm or more in any diameter.eThe number in brackets
was the immunochemistry score of p16INK4a.
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The development of RB involves sequential genetic lesions,
and the loss of RB protein (pRB) is the first step and the
basis of other biological alterations. In 1998, Schwartz
found that pRB dysregulation resulted in increased p16INK4a
expression in colon cancer, due to positive feedback [21]. In
recent years, the progressive increase of p16INK4a expres-
sion accompanying pRB dysfunction had been described in
many tumors [22]. In 2011, Witkiewicz summarized two
complementary models for the appearance of tumors with
high levels of p16INK4a [6]. In the first model, p16INK4a was
elevated in some precancerous lesions due to oncogenic
stress. If the RB1 gene was functional, the cells became sen-
escent; otherwise, they became cancerous. In the second
model, p16INK4a increased via a feedback loop in response
to pRB dysfunction and was associated with highly malig-
nant tumors. The results of the present study were consist-
ent with the second mechanism described by Witkiewicz.
Immunohistochemistry investigation of p16INK4a in RB
tumor samples had been reported with controversial re-
sults. Dimaras et al. described p16INK4a expression in 8 RC
cases, showing p16INK4a positive in the benign RC region
but negative in the RB area [4]. However, SE Coupland
and colleagues reported the reverse expression pattern
that p16INK4a was negative in RC area but positive in
poorly and moderately differentiated areas in their 23 RB
tumors [14]. Similarly, Indovina et al. described that 6 out
of 11 RB cases were 100% positive for p16INK4a and thatother cases were 5%-40% positive [13], implying that undif-
ferentiated tumor cells were positive. In our 65 cases, the
expression pattern of p16INK4a in RB was closer to what SE
Coupland described in a way that the level of p16INK4a was
increased from negative expression in well-differentiated
fleurette structures to highly strong expression in poorly
differentiated area. This pattern of p16INK4a in RB was simi-
lar to that of Ki67, but reverse to that of CRX. Therefore,
our study indicated that p16INK4a could serve as a potential
molecular marker to distinguish the level of cell differenti-
ation in RB tumors.
The classic function attributed to p16INK4a has been cell
cycle regulation in the nucleus; however, p16INK4a overex-
pression could occur in both the cytoplasm and nucleus
of malignant cells. For example, in colorectal and breast
cancers, p16INK4a exhibited strong nuclear/cytoplasmic
positivity in primary or metastatic carcinomas, whereas
negativity or low nuclear expression was observed in nor-
mal mucosa and benign fibroadenoma [23,24]. Previous
studies had shown that p16INK4a appeared in the cyto-
plasm and/or nucleus in RB tumor cells [4,13,14]. Simi-
larly, in our RB cases, the location of p16INK4a expression
largely depended on the degree of tumor differentiation,
from staining in both the cytoplasm and nucleus of poorly
differentiated cells to primary cytoplasm of moderately
differentiated cells. Moreover, negative expression of
p16INK4a was seen in both the residual retina adjacent to
the tumor and normal human retinal tissue. Nevertheless,
the significance of different sublocations of p16INK4a ex-
pression in malignant cells has not been clearly clarified
yet,which may be associated with the prognosis of the ma-
lignant tumor. Many efforts have been made to under-
stand the regulation mechanisms underlying p16INK4a
expression location within the tumor cells and its possible
therapeutic value by re-locating the dislocated p16INK4a to
the optimal subcellular site in the malignancy [25-27].
More work is needed to answer these questions in the RB
cases.
To date, the prognostic factors of RB remained a sub-
ject of intense discussion among ophthalmologists. The
only consensus was that some high-risk histopatho-
logical features, such as the presence and extent of optic
nerve invasion and the location and extent of uveal in-
vasion [28], may be predictive. Grade of tumor differen-
tiation has also been served as a key predictor of RB
prognosis for a long time. In our 65 RB cases, both RC
and FWR groups could be classified into the low grade
of RB tumors, where most of tumors expressed low level
of p16INK4a. However, the other two groups HWR and
UD could be taken as the high grade of RBs, where most
of tumors expressed high level of p16INK4a. Our results
also demonstrated tumors with high expression of
p16INK4a had higher risk features with the optic nerve
invasion and uveal invasion. These data suggested that
Liu et al. Diagnostic Pathology  (2014) 9:180 Page 7 of 7the overexpression of p16INK4a might be a risk predictor
of the poor prognosis of RB tumors.
Conclusions
In conclusion, our study demonstrates that p16INK4a expres-
sion correlates with RB differentiation. The lack of p16INK4a
expression is a reliable marker of RC, a benign RB lesion.
However, high-grade RB tumor is accompanied by an in-
crease expression of p16INK4a, as determined by rigorous
scoring approaches and multi-marker combinations. Our
conclusions are based on a series of cases devoid of any
follow-up information; thus, further investigation will be re-
quired to evaluate its value as a molecular marker of RB
prognoses and therapeutic responses.
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